Bindley Bioscience Center

Grant Opportunities

  1. NATIONAL INSTITUTE OF ALLERGIES AND INFECTIOUS DISEASES (NIAID)
    If you are interested in discussing any of the following grant opportunities, please contact Charles Buck, Director of Operations, at cbuck@purdue.edu or 494-2208. See these older announcements on the NIAID Funding Opportunities List

    1. PAR-08-026, Support of Competitive Research (SCORE) Research Advancement Award
      Application Due Date(s): Standard dates apply
      Expiration Date: September 8, 2011

    2. PAR-08-027, Support of Competitive Research (SCORE) Pilot Project Award
      Application Due Date(s): Standard dates apply
      Expiration Date: September 8, 2011



  2. Novel Approaches to Study Polymicrobial Diseases (R01)
    Application Due Date(s): Standard dates apply
    Expiration Date: May 8, 2011

    http://grants.nih.gov/grants/guide/pa-files/PA-08-091.html. This FOA encourages investigators to think beyond the one organism-one disease concept and instead to consider the fact that many diseases are caused by the synergistic and inhibitory interactions of bacteria, viruses, parasites, and fungi. Projects should include studies aimed at understanding the cellular and molecular interactions of pathogens with the normal flora as well as the interactions among pathogens themselves, and how commensal organisms can be used to prevent or treat infections. This FOA is limited to those projects that involve or are based on intermicrobial interactions that have been well documented to occur in clinical settings. In addition, extensive research is needed on the host responses to polymicrobial infections in order to develop new approaches to treat and prevent these infections. The development of co-infection models and the use of genomic and proteomic technologies to identify common virulence mechanisms and host response patterns as well as the development of diagnostic and prognostic microbial/host signature patterns are encouraged. Because of the complexity of such projects, the establishment of collaborative scientific teams, both domestic and international, with diverse scientific disciplines studying polymicrobial diseases, including microbiology, immunology, biochemistry, clinical medicine, pathology, bioengineering, material science, imaging technology, and mathematical modeling are encouraged. Research studies to be investigated under this FOA are expected to develop novel, mechanistic ideas for polymicrobial interactions. Projects to be examined include, but are not limited to the following:

    • Elucidation of the mechanisms by which viral or parasitic infections increase the risk for bacterial infection or vice versa;

    • Determination of how surface adhesions are altered during microbial interactions;

    • Identify the mechanisms by which polymicrobial infections lead to enhanced resistance of microbes to acquired or innate immunity;

    • Development of co-infection animal models or cell culture systems for multiple pathogens;

    • Development of vaccines against polymicrobial infections;

    • Use of genomics and proteomics to identify microbial virulence genes and/or proteins that may be uniquely expressed during co-infection;

    • Evaluation of host response patterns, in response to single vs. multiple infections (simultaneous or sequential activation), required to elicit synergy or inhibition;

    • Ability of bacteria to colonize or invade host tissues following recent viral infection (with the exception of HIV);

    • Development of biotherapeutics such as phage therapy and the ability of bacteria to block the pathogenicity of other bacteria (i.e. probiotic organisms);

    • Characterization of lung host responses to polymicrobial infections and lung host response patterns;

    • Polymicrobial interactions as determinants of lung disease;

    • Development of new imaging techniques for probing polymicrobial interactions;

    • Development of mathematical models and analysis tools for the study of polymicrobial interactions is encouraged.

    Application Due Date(s): Standard dates apply


  3. CANCER-RELATED FUNDING OPPORTUNITIES
    New Cancer Related Funding Opportunities: Complete list at
    http://www.purdue.edu/discoverypark/oncological/funding-opportunities/externalOpportunities.php If you are interested in discussing any of the following grant opportunities, please contact Charles Buck (cbuck@purdue.edu).


  4. Nanoscience and Nanotechnology in Biology and Medicine (R01)
    http://grants1.nih.gov/grants/guide/pa-files/PA-08-052.html
    This funding opportunity announcement (FOA) is aimed at enhancing nanoscience and nanotechnology research focused on problems in biology and medicine.

    Release/Posted: December 18, 2007
    Opening: February 5, 2008
    Submission/Receipt: Standard dates apply (please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#reviewandaward)

    AIDS Application Submission/Receipt: Standard dates apply (please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#AIDS)
    Expiration: January 8, 2011


  5. Nanoscience and Nanotechnology in Biology and Medicine (R21)
    http://grants1.nih.gov/grants/guide/pa-files/PA-08-053.html
    This funding opportunity announcement (FOA) is aimed at enhancing nanoscience and nanotechnology research focused on problems in biology and medicine.

    Release/Posted: December 18, 2007
    Opening: January 16, 2008
    Application
    Submission/Receipt:

    Standard dates apply (please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#reviewandaward)
    Expiration: January 8, 2011


  6. Cancer Prevention Research Small Grant Program (R03)
    http://grants1.nih.gov/grants/guide/pa-files/PAR-08-055.html
    This funding opportunity announcement (FOA) is designed to enhance the basic and applied cancer prevention research. The National Cancer Institute (NCI) invites applications that propose small and time-limited projects pertinent to the development of cancer chemoprevention agents, biomarkers for early cancer detection, cancer-related nutrition science, and/or clinical prevention studies that focus on specific target organs. Proposed projects may involve basic and/or translational research and/or human subjects-oriented research. However, treatment-related quality-of-life population-based studies, as well as projects focused on cancer etiology, metastasis, or treatment will be considered non-responsive to this FOA. New, as well as established, investigators in relevant fields and disciplines (e.g., chemoprevention, nutritional science, genetics, infectious agents, and early detection, including biomarker development and validation) are encouraged to apply for these small grants to test the feasibility of innovative ideas or carry out pilot studies. Ultimately, these small grants are expected to facilitate the development of full research projects (e.g., research project grants/parent R01)

    Release/Posted: December 17, 2007
    Opening: March 19, 2008
    Submission/Receipt: March 19, 2008; July 18, 2008; December 19, 2008;
    March 20, 2009; July 17, 2009; December 18, 2009;
    March 19, 2010;
    Expiration: December 10, 2010

    http://grants.nih.gov/grants/guide/pa-files/PAR-08-065.html


  7. Molecular Approaches to Diet and Pancreatic Cancer Prevention (R01)
    Application Due Date(s): Standard dates apply

    Expiration Date:   January 8, 2011

    http://grants.nih.gov/grants/guide/pa-files/PA-08-032.html


  8. Resource Program Grants in Bioformatics (P41)
    http://grants.nih.gov/grants/guide/pa-files/PA-08-180.html
    The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) solicits Resource Program Grants in Bioinformatics for supporting the continued operation, improvement, and dissemination of databases, digital information, or software tools that are unique, and of special importance to research using animal models of embryonic developmental processes. Applicants are strongly encouraged to consult with the Scientific/Research Contact listed in the program under Section VII to ensure that the proposed project reflects the objectives of this FOA and the programmatic interests of the NICHD.

    Release Date: June 18, 2008
    Application:  
    Submission/Receipt: Standard dates apply (please click on this link )
    Expiration Date: September 8, 2011



  9. Decision Making in Cancer: Single-Event Decisions (R01)
    Application Due Date(s): Standard dates apply

    Expiration Date:   January 8, 2011

    http://grants.nih.gov/grants/guide/pa-files/PA-08-063.html


  10. Advances in Biological Informatics (ABI) (NSF)
    http://www.nsf.gov/pubs/2008/nsf08563/nsf08563.htm?govDel=USNSF_25
    Program Title: Advances in Biological Informatics (ABI) Synopsis of Program: The Advances in Biological Informatics (ABI) program seeks to encourage new approaches to the analysis and dissemination of biological knowledge for the benefit of both the scientific community and the broader public. The ABI program is especially interested in the development of informatics tools and resources that have the potential to advance, or transform, research in biology supported by the Directorate for Biological Sciences at the National Science Foundation.
    Full Proposal Target Date(s):

    August 12, 2008
    Second Tuesday in August, Annually Thereafter
    August 11, 2009
    August 10, 2010

  11. IMAT PROGRAM
    If you are interested in discussing any of the following grant opportunities, please contact Perry Kirkham, Project Coordinator of Research Development Services, at pkirkham@purdue.edu or 496-3645.

    The IMAT Program (http://imat.cancer.gov/) is aimed at the development and integration of novel and emerging technologies in the support of cancer research, diagnosis, and treatment. Since 1998, the IMAT Program facilitates the accelerated development of various tools and methods benefiting cancer research and, ultimately, clinical oncological practice.
    The IMAT Program consists of the following three related themes:

    • Innovative Technologies for the Molecular Analysis of Cancer, which emphasizes research projects that are centered on the inception and early stage development of new technologies for cancer research;

    • Application of Emerging Technologies for Cancer Research, which is designed to support research projects evaluating technologies that are ready for initial clinical or laboratory application in cancer research; and

    • Innovations in Cancer Sample Preparation, which is centered on the development of novel technologies of sample preparation, purification, and processing to maximize the quality and utility of biospecimens for molecular analyses of cancer cells and their host environments without compromising donor/patient health.

    The IMAT program supports projects from the stage of technology inception through the feasibility/optimizations studies to the ultimate developmental and application phases. Through the use of appropriate funding mechanisms, the individual IMAT Program FOAs are focused either on: (1) the Phase I or high-risk exploratory portion of an investigator's scientific effort, with an emphasis on innovation; or (2) the developmental Phase II projects; or (3) combined phased innovation mechanism (Fast-Track for SBIR/STTR).

    NOTE: Whereas the scientific scopes within the main IMAT themes remain constant, FOAs with the focus on exploratory pilot phases and on developmental phases have distinct submission requirements. The complete matrix of multiple IMAT FOAs, including their scopes and basic requirements, is outlined in NOT-CA-08-003. Potential applicants interested in IMAT initiatives are strongly advised to use that NIH Guide Notice as a “switchboard” to verify which of the closely related active FOAs might be most appropriate for them to apply to.


  12. Development of New Technologies Needed for Studying the Human Microbiome (R21)
    http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-08-027.html
    The purpose of this FOA is to solicit applications to develop new and improved technologies for obtaining samples of individual microbial isolates or strains, from the human microbiota, suitable for complete genomic sequence analysis. The goal is to expand the number of reference microbial genome sequences, which in turn will aid in the analysis of the complex microbial populations resident in and on the human body.
    Release/Posted Date: July 15, 2008
    Opening Date: September 2, 2008
    Letters of Intent Receipt Date(s): September 2, 2008
    Application Due Date(s): October 2, 2008
    Peer Review Date(s): January-February 2009
    Council Review Date(s): May 2009
    Earliest Anticipated Start Date(s): July 1, 2009
    Expiration Date: October 3, 2008


  13. Diet-Induced Changes in Inflammation as Determinants of Colon Cancer (R01)
    http://grants.nih.gov/grants/guide/pa-files/PA-08-210.html
    The purpose of this FOA is to solicit applications to develop new and improved technologies for obtaining samples of individual microbial isolates or strains, from the human microbiota, suitable for complete genomic sequence analysis. The goal is to expand the number of reference microbial genome sequences, which in turn will aid in the analysis of the complex microbial populations resident in and on the human body.
    Release/Posted Date: July 18, 2008
    Opening Date: September 5, 2008
    Application Due Date(s): Standard dates apply
    Expiration Date: September 8, 2011


  14. Investigations on Primary Immunodeficiency Diseases (R01)
    http://grants.nih.gov/grants/guide/pa-files/PAR-08-206.html
    The National Institute of Allergy and Infectious Diseases (NIAID), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, will co-sponsor this FOA to support applications from institutions/organizations that propose innovative investigations in primary immunodeficiency diseases with a focus on ex vivo studies with human specimens and on studies with existing or new animal models. This FOA will also support novel clinical strategies, not including clinical trials, to detect primary immunodeficiency diseases, to identify the molecular basis of these diseases, and to develop innovative therapies for primary immunodeficiency diseases. Investigators who have no prior history of receiving independent NIH funding in this field are encouraged to apply.
    Release/Posted Date: July 18, 2008
    Opening Date: Must be submitted 30 days in advance of intended receipt date
    Letters of Intent Receipt Date(s): September 2, 2008
    Application Due Date(s): Standard dates apply
    Expiration Date: September 8, 2011


  15. Meetings, Conferences, and Networks for Research Partnerships to Improve Functional Outcomes (R13)
    http://grants.nih.gov/grants/guide/pa-files/PAR-08-207.html
    This funding opportunity announcement (FOA) solicits Conference Grant (R13/U13) applications from applicant organizations for meetings and networks that will facilitate interdisciplinary research partnership among investigators. The goal is to create opportunities for forming strong and effective multi-disciplinary scientific teams to address basic, translational, or clinical research problems in rehabilitation or management of chronic disease, including mental disorders.
    Release/Posted Date: July 18, 2008
    Opening Date: July 18, 2008
    Application Submission/Receipt Date(s): Standard dates apply
    Expiration Date: September 8, 2011


  16. LINK TO THE OFFICE OF THE VICE PRESIDENT FOR RESEARCH (OVPR)
    http://www.purdue.edu/research/vpr/funding/

About Bindley

Interdisciplinary life sciences and engineering researchers collaborate to explore new technologies and scientific knowledge that impact the broad boundaries of plant, animal, and human diseases.


Partners


Current Events

No current events were found.


Contact

Bindley Bioscience Center
1203 W. State Street
Purdue University
West Lafayette, IN 47907-2057